Share: Facebook Twitter GooglePLus LinkedIn
Activity Provided By:

MCPHS University

THE CONVERSION TO HUMAN REGULAR 500 UNITS/ML INSULIN UTILIZINGCONTINUOUS GLUCOSE MONITORING (CGM)

Access Activity

Overview / Abstract:

This CE will briefly highlight the previous standard practice for administering U-500 and examine the current available delivery device options for safe and efficacious administration of human regular insulin 500 units/ml with a dedicated U-500 syringe and an insulin pen. The safe and effective use of U-500 requires careful monitoring to optimize glycemic control while minimizing the risk of hypoglyce­mia. The role, value and usage of continuous glucose monitoring (CGM) will be discussed and demonstrated throughout this session. This session will utilize a patient case example to highlight a candidate for U-500 insulin therapy, the transition to U-500, and appropriate therapy adjustments at various intervals.

Learning Objectives:

Upon completion of this activity, the participant should be able to:

Identify candidates for human regular insulin 500 units/ml and discuss dosing strategies for its use

Explain the available delivery device options for safe and efficacious administration of human regular insulin 500 units/ml with a dedicated U-500 syringe and insulin pen

Recognize the benefits of continuous glucose monitoring to aid in the ability to dose human regular insulin 500 units/ml

Expiration

Jul 21, 2022

Discipline(s)

Pharmacy CPE

Format

Online

Cost

12.00

Credits / Hours

1

Accreditation

ACPE

Presenters / Authors / Faculty

Jennifer Goldman, RPh, PharmD, CDE, BC-ADM, FCCP

Keywords / Search Terms

MCPHS University CGM, Continuous Glucose Monitor, Insulin, Diabetes Management Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map